Assignee
CONTEXT BIOPHARMA INC
US·5 granted patents·3 pending applications·1 citations·filing 2015–2023
Top patents by PatentIndex Score
8 records- 0173US10308676B2Methods of making onapristone intermediatesCONTEXT BIOPHARMA INC·Filed 2016·Granted Jun 4, 2019·1 cites·14 claims
- 0270US2023157960A1Onapristone extended-release compositions and methodsCONTEXT BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0365US11672762B2Onapristone extended-release compositions and methodsCONTEXT BIOPHARMA INC·Filed 2020·Granted Jun 13, 2023·0 cites·21 claims
- 0465US2020376004A1Amorphous onapristone compositions and methods of making the sameCONTEXT BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 0561US10548905B2Amorphous onapristone compositions and methods of making the sameCONTEXT BIOPHARMA INC·Filed 2016·Granted Feb 4, 2020·0 cites·7 claims
- 0656US10786461B2Onapristone extended-release compositions and methodsCONTEXT BIOPHARMA INC·Filed 2015·Granted Sep 29, 2020·0 cites·16 claims
- 0754US11613555B2Methods for onapristone synthesis dehydration and deprotectionCONTEXT BIOPHARMA INC·Filed 2020·Granted Mar 28, 2023·0 cites·22 claims
- 0854US2024368211A1Processes of making onapristone and intermediates thereofCONTEXT BIOPHARMA INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →